Literature DB >> 11756681

Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes.

David A Fruman1, Gregory Z Ferl, Sam S An, Amber C Donahue, Anne B Satterthwaite, Owen N Witte.   

Abstract

Bruton's tyrosine kinase (Btk) acts downstream of phosphoinositide 3-kinase (PI3K) in a pathway required for B cell receptor (BCR)-dependent proliferation. We used DNA microarrays to determine what fraction of genes this pathway influences and to investigate whether PI3K and Btk mediate distinct gene regulation events. As complete loss-of-function mutations in PI3K and Btk alter B cell subpopulations and may cause compensatory changes in gene expression, we used B cells with partial loss of function in either PI3K or Btk. Only about 5% of the BCR-dependent gene expression changes were significantly affected by reduced PI3K or Btk. The results indicate that PI3K and Btk share target genes, and that PI3K influences additional genes independently of Btk. These data are consistent with PI3K acting through Btk and other effectors to regulate expression of a critical subset of BCR target genes that determine effective entry into the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11756681      PMCID: PMC117565          DOI: 10.1073/pnas.012605099

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  Xid-like phenotypes: a B cell signalosome takes shape.

Authors:  D A Fruman; A B Satterthwaite; O N Witte
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

2.  Discordant phenotype in siblings with X-linked agammaglobulinemia.

Authors:  M J Bykowsky; R N Haire; Y Ohta; H Tang; S S Sung; E S Veksler; J M Greene; S M Fu; G W Litman; K E Sullivan
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

3.  An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.

Authors:  J S Anderson; M Teutsch; Z Dong; H H Wortis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

4.  Immunodeficiency in protein kinase cbeta-deficient mice.

Authors:  M Leitges; C Schmedt; R Guinamard; J Davoust; S Schaal; S Stabel; A Tarakhovsky
Journal:  Science       Date:  1996-08-09       Impact factor: 47.728

5.  Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F.

Authors:  P Brennan; J W Babbage; B M Burgering; B Groner; K Reif; D A Cantrell
Journal:  Immunity       Date:  1997-11       Impact factor: 31.745

6.  A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains.

Authors:  L E Rameh; A k Arvidsson; K L Carraway; A D Couvillon; G Rathbun; A Crompton; B VanRenterghem; M P Czech; K S Ravichandran; S J Burakoff; D S Wang; C S Chen; L C Cantley
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

7.  Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase.

Authors:  K Salim; M J Bottomley; E Querfurth; M J Zvelebil; I Gout; R Scaife; R L Margolis; R Gigg; C I Smith; P C Driscoll; M D Waterfield; G Panayotou
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

8.  Immature stage B cells enter but do not progress beyond the early G1 phase of the cell cycle in response to antigen receptor signaling.

Authors:  J A Carman; R J Wechsler-Reya; J G Monroe
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

9.  Intermediate affinity interleukin-2 receptor mediates survival via a phosphatidylinositol 3-kinase-dependent pathway.

Authors:  A González-García; I Mérida; C Martinez-A; A C Carrera
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

10.  Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.

Authors:  N Solvason; W W Wu; N Kabra; X Wu; E Lees; M C Howard
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

View more
  21 in total

1.  KLF4 translation level is associated with differentiation stage of different pediatric leukemias in both cell lines and primary samples.

Authors:  Xiaoping Guo; Yongmin Tang
Journal:  Clin Exp Med       Date:  2012-05-17       Impact factor: 3.984

2.  Decreased expression of Kruppel-like factors in memory B cells induces the rapid response typical of secondary antibody responses.

Authors:  Kim L Good; Stuart G Tangye
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-02       Impact factor: 11.205

3.  Temporal genetic program following B-cell receptor cross-linking: altered balance between proliferation and death in healthy and malignant B cells.

Authors:  Laurent D Vallat; Yuhyun Park; Cheng Li; John G Gribben
Journal:  Blood       Date:  2007-01-18       Impact factor: 22.113

4.  Villous B cells of the small intestine are specialized for invariant NK T cell dependence.

Authors:  Peter Velázquez; Bo Wei; Michael McPherson; Lesley Marie A Mendoza; Sandra L Nguyen; Olga Turovskaya; Mitchell Kronenberg; Tiffany T Huang; Matthew Schrage; Lynn N Lobato; Daisuke Fujiwara; Sarah Brewer; Moshe Arditi; Genhong Cheng; R Balfour Sartor; Rodney D Newberry; Jonathan Braun
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

5.  A novel mechanism for Bcr-Abl action: Bcr-Abl-mediated induction of the eIF4F translation initiation complex and mRNA translation.

Authors:  S Prabhu; D Saadat; M Zhang; L Halbur; J P Fruehauf; S T Ong
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

6.  KLF4 suppresses transformation of pre-B cells by ABL oncogenes.

Authors:  Michael G Kharas; Isharat Yusuf; Vanessa M Scarfone; Vincent W Yang; Julia A Segre; Claudia S Huettner; David A Fruman
Journal:  Blood       Date:  2006-09-05       Impact factor: 22.113

7.  Erythroid Krüppel-like factor directly activates the basic Krüppel-like factor gene in erythroid cells.

Authors:  Alister P W Funnell; Christopher A Maloney; Lucinda J Thompson; Janelle Keys; Michael Tallack; Andrew C Perkins; Merlin Crossley
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

8.  IBL-202 is synergistic with venetoclax in CLL under in vitro conditions that mimic the tumor microenvironment.

Authors:  Yandong Shen; Kyle Crassini; Narjis Fatima; Michael O'Dwyer; Michael O'Neill; Richard I Christopherson; Stephen P Mulligan; O Giles Best
Journal:  Blood Adv       Date:  2020-10-27

Review 9.  Inhibitors of B-cell receptor signaling for patients with B-cell malignancies.

Authors:  Michael Y Choi; Thomas J Kipps
Journal:  Cancer J       Date:  2012 Sep-Oct       Impact factor: 3.360

Review 10.  Roles of Krüpel-like factor 4 in normal homeostasis, cancer and stem cells.

Authors:  Paul M Evans; Chunming Liu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2008-07       Impact factor: 3.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.